The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Apolipoprotein E structure: insights into function
Abstract
Human apolipoprotein E (apoE) is a member of the family of soluble apolipoproteins. Through its interaction with members of the low-density lipoprotein receptor family, apoE has a key role in lipid transport both in the plasma and in the central nervous system. Its three common structural isoforms differentially affect the risk of developing atherosclerosis and neurodegenerative disorders, including Alzheimer's disease. Because the function of apoE is dictated by its structure, understanding the structural properties of apoE and its isoforms is required both to determine its role in disease and for the development of therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several biophysical studies have shown that apoE displays low thermodynamic stability and significant conformational plasticity, and allelic differences as well as single point mutations have been shown to affect protein conformation and to hinder physiological function”
From Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy (2018) · cites this paper as [13]
In the citing paper
“Several biophysical studies have shown that apoE displays low thermodynamic stability and significant conformational plasticity, and allelic differences as well as single point mutations have been shown to affect protein conformation and to hinder physiological function”
From Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy (2018) · cites this paper as [13]
In the citing paper
“Inter-domain interactions within apoE have been hypothesized to underlie key conformational changes related to apoE function [44], [45].”
From Biophysical Analysis of Apolipoprotein E3 Variants Linked with Development of Type III Hyperlipoproteinemia (2011) · cites this paper as [44]
In the citing paper
“Several studies have suggested that the structural and biophysical properties of apoE can dictate the function of the protein and have provided insight into the mechanisms by which apoE is involved in cardiovascular and neurological diseases [42], [43], [44], [45], [46], [47], [48], [49].”
From Biophysical Analysis of Apolipoprotein E3 Variants Linked with Development of Type III Hyperlipoproteinemia (2011) · cites this paper as [44]
In the citing paper
“of the second unfolding transition of apoE3 variant (Table 3) that corresponds to the unfolding of the N-terminal domain where the K146E mutation is located [13], [44], [65].”
From Biophysical Analysis of Apolipoprotein E3 Variants Linked with Development of Type III Hyperlipoproteinemia (2011) · cites this paper as [44]
In the citing paper
“Apo E4 isoform is associated with elevated total and LDL-cholesterol levels, due to the higher affinity of apo E4 for VLDL and LDL”
From Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with the APOE p.Leu167del Mutation (2013) · cites this paper as Hatters DM et al. 2006
In the citing paper
“Mutated ApoE2 (Arg158Cys) exhibits only 2% affinity to LDL receptor compared to the wide type ApoE3 isoform [13]”
From A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation (2024) · cites this paper as [13]
In the citing paper
“Biophysical and computational analyses suggest that unfolding of the N-terminal domain constitutes a necessary conformational change for lipid binding and apoE function (19).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [19]
In the citing paper
“ApoE variants with lower thermodynamic stability and changes in conformational plasticity have been shown to have altered interdomain interactions and defective physiological functions (19, 24 -28).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [19]
In the citing paper
“First, apoE4 preferentially forms a “molten globule state” that ultimately reduces the in vitro stability of apoE4 relative to the other isoforms.”
From Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels (2008) · cites this paper as Hatters et al., 2006
In the citing paper
“Second, apoE4 forms a unique salt bridge interaction between Arg-61 in the N terminal and Glu-255 in the carboxy-terminal domain.”
From Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels (2008) · cites this paper as Hatters et al., 2006
In the citing paper
“ApoE contains two independently folded functional domains; these are a 22-kDa N-terminal domain (residues 1–191) and a 10-kDa C-terminal domain (residues 216–299) linked by a hinge region (18, 19).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [19]
In the citing paper
“This domain interaction mediated by a salt bridge formation between Arg-61 and Glu-255 is unique to apoE4 (Fig. 1) [15].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [15]
Citations
Cites
2 retracted
Ajees, A. A., Anantharamaiah, G. M., Mishra, V., Hussain, M. M., & Murthy, H. M. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506877103 · Cited by 204
RetractedKumar, M., Carson, M. A., Hussain, M. M., & Murthy, H. M. K. (2002) · Biochemistry · doi:10.1021/bi026069w · Cited by 33
RetractedThe Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm
Wright, P. E., & Dyson, H. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3110 · Cited by 2,968
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Self-citationMolten Globule and Protein Folding
Ptitsyn, O. B. (1995) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60546-x · Cited by 1,222
Flagged first, then by citations
1 of the 88 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Pitas, 1980, Cell surface receptor binding of phospholipid–protein complexes containing different ratios of receptor-active and -inactive E apoprotein, J. Biol. Chem., 255, 5454, 10.1016/S0021-9258(19)70808-4 · DOI · Paper page
Cited by
Sorted by citations
Items 501–583 of 583
Biologie, A. F., & Dieckmann, M. (2010)
Thongket, P., Chatsuriyawong, S., & Sukhumsirichart, W. (2013)
Wisam, N. I., Norsidah, K.-Z., Samsul, D., Zamzila, A., Rafidah, H. M., & At, N. (2015) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v14i2.434
Síndrome nefrótico asociado a mutación de la apolipoproteína-E. ¿Nueva entidad clínica?
de Anda, R. G., & Casados, M. D. C. A. (2012)
Fibrin Formation and Dissolution in the Progression of Amyloid-Beta Pathology in Alzheimer's Disease
Paul, J. (2025) · Digital Commons - RU (Rockefeller University) · doi:10.48496/m50g-qv97
Lee, Y. (2012) · Georgetown University-Graduate School of Arts & Sciences
Aronsen, E. (2009) · Duo Research Archive (University of Oslo)
Alzheimer’s Disease Therapeutics Targeting Apolipoprotein E
Liao, F., & Holtzman, D. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00010-1
Alzheimer’s disease: Risk factors and therapeutic targets
Pokhrel, L. (2015) · Journal of Coastal Life Medicine · doi:10.12980/jclm.3.2015j5-57
“It was also found less effective to remove the toxins and repair the problematic neurons[24].”
BackgroundSampedro, F. P. (2016) · TDX (Tesis Doctorals en Xarxa)
Strzelecki, A., Kortas‐Stempak, B., & Zdrojewski, Z. (2015)
Dorey, E. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6258
An equilibrium model for the formation of apoC-II amyloid fibrils
Yang, S. (2012) · Minerva Access (University of Melbourne)
Mass Spectrometry and Protein Analysis: Structure, Oligomerization and Interaction
Wang, H. (2016) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k71z42t9
Hawley, B. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6225
“The lipid binding region of APOE is in the C-terminal domain (residues 244-272) (81).”
BackgroundThe interactive impact of omega-3 fatty acids, APOE genotype and sex hormones on cognition
Pontifex, M. G. (2020) · UEA Digital Repository (University of East Anglia)
APOE as a Risk Factor for Age‐Related Cognitive Impairment
Korthauer, L. E., & Driscoll, I. F. (2020) · The Wiley Encyclopedia of Health Psychology · doi:10.1002/9781119057840.ch35
Polymorphisms of apolipoprotein E in the Afro-descendant population of Buenaventura, Colombia
Perdomo, V. A., Ortega, D. C., & Barreto, G. (2020) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2020.10.010
Conformational Reorganisation of Apolipoprotein E Triggered by Phospholipid AssemblyPreprint
Prakashchand, D. D., & Mondal, J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.255299
Strattan, L. E. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.097
Fast linear gate and stretcher
Watanabe, S., & Mishina, M. A. (1974) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Lipoprotein Metabolism and the Treatment of Lipid Disorders
Freeman, M. W. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00042-3
Faculty Opinions recommendation of Direct transcriptional effects of apolipoprotein E.
Rujescu, D., & Jung, M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726091077.793558447
Pandit, S. (2022) · Biomolecular NMR Assignments · doi:10.1007/s12104-022-10078-3
Changes of urinary proteome in high-fat diet ApoE -/- micePreprint
Hua, Y., Wenshu, M., Wei, J., Liu, Y., & Gao, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.27.505538
Genetic lipid disorders, the APOE gene and Familial Dysbetalipoproteinemia
Heidemann, B. E. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1408
Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotypePreprint
Lawler, P. E., Bollinger, J. G., Schindler, S. E., Hodge, C. R., Iglesias, N. J., Krishnan, V., Coulton, J. B., Li, Y., Holtzman, D. M., & Bateman, R. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522616
“ApoE is expressed in the periphery by hepatocytes and, to a lesser extent, by macrophages and monocytes [7], [10].”
BackgroundThe profiling and imaging of sterol molecules in the human brain
Griffiths, L. (2023) · Cronfa (Swansea University) · doi:10.23889/suthesis.62587
Glial Cells in Alzheimer’s Disease
Verkerke, M. L. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1838
Human Genetic as Risk Factors for COVID-19 Progression
Hosney, M., Sallam, R., & Sayed, M. (2023) · Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology/Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology · doi:10.21608/eajbsc.2023.322926
A Comprehensive Review on the Newer Therapeutic Approaches in Treating Alzheimer’s Disease
Prakash, R., Jayaraman, R., Palei, N. N., Prakash, D. J., & Ronald, D. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_40-1
Thermal Remodeling of Human HDL Particles Reveals Diverse Subspecies
Lutomski, C. A., El‐Baba, T. J., Clemmer, D. E., & Jarrold, M. F. (2024) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.4c00228
A Comprehensive Review on the Newer Therapeutic Approaches in Treating Alzheimer’s Disease
Prakash, R., Jayaraman, R., Palei, N. N., Prakash, D. J., & Ronald, D. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_40
Narayanaswami, V., Reddick, I., Celis, G., Pal, S., Nguyen, J., Deepa, S., & Garai, K. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5158139
Reddick, I., Celis, G., Pal, S., Nguyen, J., Saraswathi, D., Garai, K., & Narayanaswami, V. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110421
Correas, Á. G., Stromsnes, K., Lupu, R. I., & González, G. O. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_29-1 · Cited by 1
Zubair, U., Ali, A., Nadeem, A., & Hussain, T. (2025) · Research in Cardiovascular Medicine · doi:10.4103/rcm.rcm_86_24
Thakur, S., Singh, B., & Singh, R. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102190
Di, C., Tang, T., Wu, H., Gan, J., Shi, Z., Yi, T., Chen, R., Liu, S., & Ji, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251393713
“44 Most of the cholesterol in the adult brain (about 70% to 80”
Yu, J., Liu, X., Ji, H., Zhang, Y., Zhan, H., Zhang, Z., Wen, J., & Wang, Z. (2023) · Figshare · doi:10.6084/m9.figshare.22620479
Meuret, C. J., Hu, Y., Smadi, S., Bantugan, M. A., Xian, H., Martinez, A. E., Krauss, R. M., Ma, Q. L., Nedelkov, D., & Yassine, H. N. (2024) · Figshare · doi:10.6084/m9.figshare.26591264
Yu, J., Liu, X., Ji, H., Zhang, Y., Zhan, H., Zhang, Z., Wen, J., & Wang, Z. (2023) · Figshare · doi:10.6084/m9.figshare.22620476
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24844648
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24844709
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654539
Lennol, M. P., Sánchez-Domínguez, I., Cuchillo‐Ibáñez, I., Camporesi, E., Brinkmalm, G., Alcolea, D. A., Fortea, J., Lleó, A., Sòria, G., Aguado, F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21485336
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654542
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654536
Donovan, K. W., Stefan, E., Bajrami, B., Bennion, M., Huff, S., Mustafa, D. N., Su, M.-J., Dragan, S., Sciabola, S., Chou, Y.-Y., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2025.12.005
Docking and Molecular Interaction of Apolipoprotein E with Plasma Lipoproteins
Monteiro, V. K. F., Rodrigues, M. V. F., de Alencar, S. A., & Monteiro, N. D. K. V. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_3-1
APOE and Proteomics in Chronic Inflammation
Shvetcov, A., & Finney, C. A. (2026) · Springer eBooks · doi:10.1007/978-3-031-52641-1_82-1
Rôle de l'apoliprotéine E dans le cycle du virus de l'hépatite C
Lefèvre, M. (2014) · theses.fr (ABES) · doi:10.70675/f91c33acz493dz464bza628zd78da966c293
Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
García‐González, L. (2020) · theses.fr (ABES) · doi:10.70675/a04672c0z1f4az472ezbcd5zbea446eac50c
Hypercholestérolémie familiale : recherche de nouveaux gènes et étude des formes polygéniques
Ghaleb, Y. (2017) · theses.fr (ABES) · doi:10.70675/ab0b16eez4c40z4cb7zb42fzb7740e0c98ea
Hardy, L. M. (2019) · theses.fr (ABES) · doi:10.70675/2f5f4b0dzc92fz4cb4z9c5bzeb6d3fd3e791
Studying the role of human Amyloid Precursor Protein (APP) during human cortical neurogenesis
Shabani, K. (2021) · theses.fr (ABES) · doi:10.70675/2deeb337z2d8ez4a8dzaf55z268de3428ac9
Étude de l'interaction de l'apolipoprotéine E avec le virus de l'hépatite E et le virus Zika
Tréguier, Y. (2022) · theses.fr (ABES) · doi:10.70675/2670b253z6927z4dd5z9cbez44dc79fdddbf
Jenseits von APP, PSEN1, PSEN2 und APOE – was lehrt uns das Genom noch?
Behl, C. (2026) · Springer eBooks · doi:10.1007/978-3-662-72210-7_16
Luo, R., Zhang, Y., Tan, X., & 邵龙泉 (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.05.021
Docking and Molecular Interaction of Apolipoprotein E with Plasma Lipoproteins
Monteiro, V. K. F., Rodrigues, M. V. F., de Alencar, S. A., & Monteiro, N. D. K. V. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_3
APOE and Proteomics in Chronic Inflammation
Shvetcov, A., & Finney, C. A. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_82
Gillet, J.-N. (2026) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2026.2671163
“Fourth, the authors employ the outdated AMBERff03 force field, which is not optimized for proteins containing extensive IDRs; more appropriate choices would include force fields improved for intrinsically disordered proteins (IDPs), such as CHARMM36m (Huang et al., 2017) or ff14IDPSFF (Song et al., 2017).”
InfluentialLietzke, E. E., Saeb, D., Aldrich, E. C., de Menezes, R. F., Bruce, K. D., & Sprenger, K. G. (2026) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2026.06.002 · Cited by 1
Apolipoprotein E in drug delivery systems—targeted pharmacotherapeutics
Pandey, J., & Jain, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00009-0
Apolipoprotein E and precision medicine: Individualized disease management approaches
Singh, V., Shirbhate, E., Kore, R., Veerasamy, R., Koch, B., Tiwari, A. K., & Rajak, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00012-0
Kaur, A., Murthy, S., Bharath Kumar, D. R., Gokulakrishnan, S., Philantharopa, U. P. B., & Narajji, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00010-7
ApoE as a biomarker and therapeutic target in atherosclerotic cardiovascular disease
Leo, A., Kumar, A., Harish, V., Singh, S. K., & Manasa, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00015-6
Lu, Q.-X., & Guan, W. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118316
17α-Estradiol Confers Limited Protection Against APOE4 Phenotypes in Middle-Aged Female MicePreprint
McGill, C. J., Christensen, A., Namvari, S., Thorwald, M. A., Anson, H., Vermulst, M., Finch, C. E., Benayoun, B. A., & Pike, C. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743074
“APOE3 and APOE4 differ in their lipid-binding efficiency due to a structural variation at amino acid position 112, with APOE3 being more efficient in binding lipids and stabilizing lipoproteins [42].”
Metkar, V., Benedicto, V., Zheng, J., Zivkovic, A. M., Plascencia, N. D., Gredig, T., & Narayanaswami, V. (2026) · The Journal of Membrane Biology · doi:10.1007/s00232-026-00393-4
“It serves as a ligand for the low-density lipoprotein receptor (LDLr) family of proteins that facilitate cellular uptake and receptor-mediated endocytosis of lipoproteins (Hatters et al. 2006; Hauser et al. 2011; Weisgraber 1994).”
Yang, H.-C., DeKoster, G., Baban, B. A., Frieden, C., & Gross, M. L. (2026) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.6c00167
Šimončičová, E., Verkerke, M., Ibáñez, F. G., Bourgeois, R., Picard, K., Khakpour, M., Julia, T. C. W., Hol, E. M., & Tremblay, M. (2026) · Neuromethods · doi:10.1007/978-1-0716-5456-9_6
Rezek, M. B. M., Ivanich, K. L., Aware, C. B., Lin, A., & Wan, C. (2026) · British Journal Of Nutrition · doi:10.1017/s000711452610871x
Namba, N., Ariyoshi, S., Shimba, A., Shiroshita, H., Ohgita, T., & Saito, H. (2026) · ACS Omega · doi:10.1021/acsomega.6c09295
Metadata
- Authors
- Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Weisgraber, Karl H.
- ORCID
- Hatters, Danny M.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 31
- Issue
- 8
- Pages
- 445-454
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W2051394059
- Cited by
- 583
- References
- 88
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 26 · 2023: 32 · 2022: 34 · 2021: 37 · 2020: 22 · 2019: 21 · 2018: 24 · 2017: 25 · 2016: 32 · 2015: 32 · 2014: 42 · 2013: 24 · 2012: 42
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Trends in Biochemical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG020235, P01AG022074)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- apolipoprotein E, protein structure, APOE isoforms, low-density lipoprotein receptor family, lipid transport, atherosclerosis, Alzheimer's disease, neurodegenerative diseases, central nervous system, treatment options
- MeSH terms
- Animals, Apolipoproteins E, Humans, Models, Molecular, Protein Binding, Protein Folding, Neurodegenerative Diseases, Protein Isoforms, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
